144 0000353278 XXXXXXXX LIVE 0001598599 Innate Pharma SA 001-39084 117, Avenue de Luminy - BP 30191 Marseille I0 13009 33-0-4-30-30-30-30 Novo Nordisk A/S 10% Stockholder Ordinary Shares, nominal value (euro)0.05 per share Portzamparc

1 boulevard Haussmann Paris I0 75009

921897 1972859.00 92189798 05/30/2025 Euronext Nasdaq Ordinary Shares, (euro)0.05 nominal value per share 06/11/2006 Acquisition Issuer N 4691651 06/11/2006 Cash Ordinary Shares, (euro)0.05 nominal value per share 12/18/2009 Acquisition Issuer N 881057 12/18/2009 Cash Ordinary Shares, (euro)0.05 nominal value per share 06/23/2014 Acquisition Issuer N 250000 06/23/2014 Cash Ordinary Shares, (euro)0.05 nominal value per share 12/28/2016 Acquisition Issuer N 142000 12/28/2016 Cash Ordinary Shares, (euro)0.05 nominal value per share 01/18/2017 Licensing Deal Issuer N 600000 01/18/2017 Novo Nordisk A/S received the ordinary shares in connection with a licensing deal. Ordinary Shares, (euro)0.05 nominal value per share 10/17/2019 Acquisition Issuer N 909000 10/17/2019 Cash Ordinary Shares, (euro)0.05 nominal value per share 12/08/2020 Licensing Deal Issuer N 3343748 12/08/2020 Novo Nordisk A/S received the ordinary shares in connection with a licensing deal. Y The sales are expected to occur on the Euronext Paris. 05/30/2025 /s/ Martin Huseboe